Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection

Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection

<p>HCV infects 170 million persons worldwide and is a serious global health problem. Genotype-3a is the dominant genotype in newly diagnosed infections within the UK and has a high response rate to interferon therapy, with up to 70% patients achieving a sustained virological response (SVR). Th...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Humphreys, I, Isla S. Humphreys
Kolejni autorzy:	Barnes, E
Format:	Praca dyplomowa
Język:	English
Wydane:	2011
Hasła przedmiotowe:	Infectious diseases Biology (medical sciences) Immunology

Podobne zapisy

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
od: Hennig, B, i wsp.
Wydane: (2008)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
od: Antrobus, R
Wydane: (2014)

Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
od: Gupta, P
Wydane: (2014)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
od: Kelly, C
Wydane: (2013)

Aspects to T-cell phenotype during infection with HIV, CMV and Hepatitis C virus
od: Northfield, J
Wydane: (2008)

Contribution of monocytes to immunopathology during influenza A virus infection
od: Cole, S, i wsp.
Wydane: (2014)

Functional impact of CD161 on T cells
od: Smith, K
Wydane: (2013)

B cell and antibody responses to influenza a virus in human
od: Huang, K
Wydane: (2011)

mTOR regulates T cell exhaustion and PD-1–targeted immunotherapy response during chronic viral infection
od: Satomi Ando, i wsp.
Wydane: (2023-01-01)

The role of the cytoplasmic domain of the macrophage scavenger receptor MARCO in adhesion and uptake
od: Kroos, M
Wydane: (2008)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
od: Ronan, E
Wydane: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
od: Griffiths, K
Wydane: (2012)

HLA-B51 associated HIV-1 viral control
od: Peng, Y
Wydane: (2013)

The role of T cell immunity in natural influenza A infection in a UK cohort: flu watch
od: Wang, L
Wydane: (2014)

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile
od: Eyre, D, i wsp.
Wydane: (2013)

Implications of HCV genotype 3 specific immunity on cross-reactive vaccine design
od: von Delft, A, i wsp.
Wydane: (2014)

Dynamics of co-infection in fish: A review of pathogen-host interaction and clinical outcome
od: Ekemini Moses Okon, i wsp.
Wydane: (2023-12-01)

Variation of HLA class I (-A and -C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon
od: Clauvis Kunkeng Yengo, i wsp.
Wydane: (2020-10-01)

Liver-stage vaccines for malaria
od: Longley, RJ
Wydane: (2013)

Function, phenotype and development of human CD161+CD8 T cells
od: Walker, LJ
Wydane: (2012)

Memory T cell responses in influenza A infection and vaccination in humans
od: Chui, C
Wydane: (2012)

NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice
od: Ha-Na Lee, i wsp.
Wydane: (2022-02-01)

Human papillomavirus type 16 and 18 viral loads as predictors associated with abnormal cervical cytology among women in Saudi Arabia
od: D.A. Obeid, i wsp.
Wydane: (2020-02-01)

Hepatitis B vaccination
od: Pollard, A
Wydane: (2007)

Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth
od: Youchao Dai, i wsp.
Wydane: (2023-04-01)

IRGM1 supports host defense against intracellular bacteria through suppression of type I interferon in mice
od: Prashant Rai, i wsp.
Wydane: (2023-11-01)

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
od: Simone A. Thair, i wsp.
Wydane: (2021-01-01)

A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion
od: Horton, Brendan, i wsp.
Wydane: (2020)

Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells
od: Shirin Nkongolo, i wsp.
Wydane: (2023-01-01)

Cross-reactive antibodies facilitate innate sensing of dengue and Zika viruses
od: Laura K. Aisenberg, i wsp.
Wydane: (2022-06-01)

Immunopathogenic CSF TCR repertoire signatures in virus-associated neurologic disease
od: Satoshi Nozuma, i wsp.
Wydane: (2021-02-01)

Characterisation of expression and function of respiratory epithelial CD1d
od: Hajipouran Benam, K
Wydane: (2014)

Potently neutralizing human mAbs against the zoonotic pararubulavirus Sosuga virus
od: Helen M. Parrington, i wsp.
Wydane: (2023-04-01)

Characterisation of the immune response to PARV4
od: Simmons, RA
Wydane: (2011)

Protocol for influenza A virus infection of mice and viral load determination
od: Ioanna-Evdokia Galani, i wsp.
Wydane: (2022-03-01)

Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches
od: Pearson, FE
Wydane: (2011)

Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection
od: Kai Deng, i wsp.
Wydane: (2023-04-01)

Basophil-derived IL-4 promotes cutaneous Staphylococcus aureus infection
od: Juan-Manuel Leyva-Castillo, i wsp.
Wydane: (2021-11-01)

Ebola virus protein VP40 stimulates IL-12– and IL-18–dependent activation of human natural killer cells
od: Hung Le, i wsp.
Wydane: (2022-08-01)

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
od: McNaughton, AL, i wsp.
Wydane: (2022)